Aphios Corporation – Product Pipeline Review

Global Markets Direct’s, ‘Aphios Corporation – Product Pipeline Review – 2016’, provides an overview of the Aphios Corporation’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Aphios Corporation, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data.


The report provides a snapshot of the pipeline therapeutic landscape of Aphios Corporation

The report provides overview of Aphios Corporation including its business description, key facts, and locations and subsidiaries

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report assesses Aphios Corporation’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

The report features Aphios Corporation’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

Evaluate Aphios Corporation’s strategic position with total access to detailed information on its product pipeline

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for Aphios Corporation

Identify potential new clients or partners in the target demographic

Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Aphios Corporation’s pipeline depth and focus of pipeline therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 6

List of Figures 6

Aphios Corporation Snapshot 7

Aphios Corporation Overview 7

Key Information 7

Key Facts 7

Aphios Corporation - Research and Development Overview 8

Key Therapeutic Areas 8

Aphios Corporation - Pipeline Review 12

Pipeline Products by Stage of Development 12

Pipeline Products - Monotherapy 13

Pipeline Products - Partnered Products 14

Partnered Products/Combination Treatment Modalities 15

Aphios Corporation - Pipeline Products Glance 16

Aphios Corporation - Clinical Stage Pipeline Products 16

Phase II Products/Combination Treatment Modalities 16

Phase I Products/Combination Treatment Modalities 17

Aphios Corporation - Early Stage Pipeline Products 18

Preclinical Products/Combination Treatment Modalities 18

Discovery Products/Combination Treatment Modalities 19

Aphios Corporation - Drug Profiles 20

APH-0812 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

APH-0703 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

AMPI-109 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

APH-0201 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

APH-0701 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

APH-0907 25

Product Description 25

Mechanism of Action 25

R&D Progress 25

APH-0911 26

Product Description 26

Mechanism of Action 26

R&D Progress 26

APH-0912 27

Product Description 27

Mechanism of Action 27

R&D Progress 27

APH-1201 28

Product Description 28

Mechanism of Action 28

R&D Progress 28

APH-1305 29

Product Description 29

Mechanism of Action 29

R&D Progress 29

camptothecin 30

Product Description 30

Mechanism of Action 30

R&D Progress 30

dronabinol 31

Product Description 31

Mechanism of Action 31

R&D Progress 31

HIV vaccine 32

Product Description 32

Mechanism of Action 32

R&D Progress 32

Hypericin 33

Product Description 33

Mechanism of Action 33

R&D Progress 33

paclitaxel 34

Product Description 34

Mechanism of Action 34

R&D Progress 34

paclitaxel phospholipid 35

Product Description 35

Mechanism of Action 35

R&D Progress 35

Sperol 36

Product Description 36

Mechanism of Action 36

R&D Progress 36

APH-0202 37

Product Description 37

Mechanism of Action 37

R&D Progress 37

APH-0804 38

Product Description 38

Mechanism of Action 38

R&D Progress 38

APH-1403 39

Product Description 39

Mechanism of Action 39

R&D Progress 39

APP-0205 40

Product Description 40

Mechanism of Action 40

R&D Progress 40

APP-069 41

Product Description 41

Mechanism of Action 41

R&D Progress 41

APP-309 42

Product Description 42

Mechanism of Action 42

R&D Progress 42

APP-401 43

Product Description 43

Mechanism of Action 43

R&D Progress 43

Marinus 44

Product Description 44

Mechanism of Action 44

R&D Progress 44

Aphios Corporation - Pipeline Analysis 45

Aphios Corporation - Pipeline Products by Target 45

Aphios Corporation - Pipeline Products by Route of Administration 46

Aphios Corporation - Pipeline Products by Molecule Type 47

Aphios Corporation - Pipeline Products by Mechanism of Action 48

Aphios Corporation - Recent Pipeline Updates 49

Aphios Corporation - Dormant Projects 50

Aphios Corporation - Locations And Subsidiaries 51

Head Office 51

Appendix 52

Methodology 52

Coverage 52

Secondary Research 52

Primary Research 52

Expert Panel Validation 52

Contact Us 52

Disclaimer 53

List of Tables

List of Tables

Aphios Corporation, Key Information 7

Aphios Corporation, Key Facts 7

Aphios Corporation – Pipeline by Indication, 2016 10

Aphios Corporation – Pipeline by Stage of Development, 2016 12

Aphios Corporation – Monotherapy Products in Pipeline, 2016 13

Aphios Corporation – Partnered Products in Pipeline, 2016 14

Aphios Corporation – Partnered Products/ Combination Treatment Modalities, 2016 15

Aphios Corporation – Phase II, 2016 16

Aphios Corporation – Phase I, 2016 17

Aphios Corporation – Preclinical, 2016 18

Aphios Corporation – Discovery, 2016 19

Aphios Corporation – Pipeline by Target, 2016 45

Aphios Corporation – Pipeline by Route of Administration, 2016 46

Aphios Corporation – Pipeline by Molecule Type, 2016 47

Aphios Corporation – Pipeline Products by Mechanism of Action, 2016 48

Aphios Corporation – Recent Pipeline Updates, 2016 49

Aphios Corporation – Dormant Developmental Projects,2016 50

List of Figures

List of Figures

Aphios Corporation – Pipeline by Top 10 Indication, 2016 9

Aphios Corporation – Pipeline by Stage of Development, 2016 12

Aphios Corporation – Monotherapy Products in Pipeline, 2016 13

Aphios Corporation – Pipeline by Top 10 Target, 2016 45

Aphios Corporation – Pipeline by Route of Administration, 2016 46

Aphios Corporation – Pipeline by Molecule Type, 2016 47

Aphios Corporation – Pipeline Products by Top 10 Mechanism of Action, 2016 48


Discounts available for multiple report purchases.

+44 (0) 161 359 5414

Saved reports